Tag Archive | "Novartis"

Novartis and Aduro Biotech in immuno-oncology pact

Tags: , ,


Aduro Biotech announced the establishment of a major collaboration with Novartis Read the full story

Arrowhead acquires Novartis RNAi R&D portfolio

Tags: , , ,


Arrowhead Research announced the acquisition of Novartis' entire RNAi research and development portfolio and associated assets Read the full story

More merger talks for Claris Lifesciences: Pfizer, Amneal, Novartis…

Tags: , , , ,


India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the Read the full story

Novartis eyes for more pharma deals in Israel

Tags: , , ,


Novartis , the world's biggest pharmaceutical (big pharma) company, recently increased its interest in Israel to sign pharma deals. For a long time, the company was active in marketing and clinical trials in Israel, and now it is involved in investment as well. Read the full story

Aspen Pharmacare acquires Mono-Embolex rights from Novartis

Tags: , , ,


Aspen has entered into an agreement with Novartis in terms of which it will acquire the rights to Mono-Embolex Read the full story

Array Biopharma acquires encorafenib rights from Novartis

Tags: , ,


Array BioPharma has reached a definitive agreement with Novartis Pharma to acquire worldwide rights to encorafenib Read the full story

Novartis and Qualcomm Ventures punt $100 million on early stage companies

Tags: , , ,


Novartis Pharmaceuticals announced the establishment of a joint investment company with Qualcomm Ventures to target early stage companies Read the full story

Novartis and BioLineRx in drug discovery pact

Tags: , ,


BioLineRx has entered into a multi-year strategic collaboration agreement with Novartis Pharma designed to facilitate development and commercialization of Israeli-sourced drug candidates Read the full story

Array Biopharma regains binimetinib from Novartis

Tags: , , ,


Array BioPharma has reached a definitive agreement with Novartis to regain full worldwide rights to binimetinib, a MEK inhibitor in three Phase 3 trials Read the full story

CSL has acquired the Flu vaccine business from Novartis

Tags: , , ,


Novartis announced has entered an agreement that CSL has acquired its influenza vaccine business in a $275 million deal that will require regulatory approval before it closes by the end of the second half of 2015. Read the full story